Cannabis Industry Growth Report: Investment, Regulation & Consumer Insights

The cannabis market is estimated at USD 72.83 billion in 2025 and is projected to reach USD 125.76 billion by 2030, at a CAGR of 11.5% from 2025 to 2030. The cannabis market continues to grow due to increased legalization, higher therapeutic demand, growing consumer acceptance, and the combination of direct and indirect needs for medical and recreational products. Advances in edibles and vapes are also driving a stronger focus on quality control and safety testing. Rising health trends and related clinical research are refining regulations, while increased scrutiny on product contents and potency have raised awareness about safe use among consumers. Additionally, greater regulatory oversight, market expansion, and the public debate surrounding cannabis are boosting the demand for reliable, standardized cannabis testing and compliance solutions.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=201768301

By application, nutraceutical & wellness form the fastest-growing segment in the global cannabis market.

Nutraceutical and wellness-use cannabis includes cannabis-based products designed to support health, nutrition, and overall wellness without producing highly potent psychoactive effects. These products are often made with cannabinoids like CBD and smaller amounts of THC, which have therapeutic benefits. They are used to help manage stress, anxiety, sleep issues, mild inflammatory conditions, chronic pain, and skin health. Nutraceutical and wellness cannabis products come in various formats, including CBD oil, capsules, gummies, topical balms, cannabis-infused beverages, skincare products, and functional edibles. The shift toward nutraceuticals and wellness cannabis products marks a move away from traditional recreational use, focusing instead on balance and prevention. This trend often appeals to health-conscious consumers seeking “natural”, plant-based alternatives to support their health and wellness, without the psychoactive effects typically associated with high-THC recreational cannabis.

By compound type, the CBD–dominant segment holds the second-largest market share in the cannabis market.

CBD is a non-psychoactive compound that helps balance sleep, pain, and stress, with additional properties against inflammation; it has received FDA approval for treating epilepsy, and other health benefits are rapidly expanding in wellness, skincare, and sports recovery. Edibles, especially gummies, are in demand because of their convenience and accuracy of dosing. Brightside, a line of micro-dose THC gummies combined with CBD, CBG, and CBC for targeted wellness, was launched by Charlotte’s Web in May 2025. Advances in supercritical CO2 extraction and the rising need for personal plant-based self-care products continue to drive CBD market growth.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=201768301

Based on region, North America holds the largest share in the cannabis market during the forecast period.

North America holds the largest share in the cannabis market during the forecast period, driven by growing legalization for medical and recreational purposes, clinical research that validates the therapeutic benefits of cannabis, consumer acceptance of cannabis products, and product innovation in edibles, topicals, and infused beverages. Demand for plant-based wellness and alternatives to treat chronic pain, anxiety, and sleeplessness is a further stimulant for market growth. The US Food and Drug Administration (FDA) oversees cannabis-derived medicines, the Drug Enforcement Administration (DEA) regulates controlled substances, Health Canada manages Canada’s cannabis framework, and state-level boards oversee local medical and recreational markets.

The report profiles key players such as Canopy Growth Corporation (Canada), Curaleaf (US), Cresco Labs (US), Green Thumb Industries (GTI) (US), Tilray Brands (US), Aurora Cannabis Inc. (Canada), Trulieve (US), Medmen (US), Blüm Holdings Inc. (US), Organigram Global (Canada), Terrascend (US), Village Farms International Inc. (US), Verano (US), The Cronos Group (Canada), and Medical Marijuana, Inc. (US).

The Growing Cannabis Market: A Path to Billions

Introduction

In recent years, the global cannabis industry has witnessed a remarkable transformation, evolving from the shadows of illegality into a thriving, legitimate market with substantial growth potential. In 2022, the global cannabis market was estimated to be valued at a staggering USD 27.7 billion, and experts project it to skyrocket to USD 82.3 billion by 2027. This rapid expansion represents a remarkable Compound Annual Growth Rate (CAGR) of 24.3% in terms of market value. A significant contributor to this upward trajectory is the medical segment, with cannabis finding its place in treating a variety of medical conditions, including anxiety, gastrointestinal disorders, seizures, and epilepsy. The proliferation of cannabis dispensaries worldwide is expanding the reach of cannabis products, promising a bright future for the industry.

Download PDF brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=201768301

Driving Factors for Growth

Several key factors are fueling the growth of the cannabis industry on a global scale. The first of these is the surging demand for cannabis products, driven by shifting societal trends. People across the world, facing increasing stress and burnout from work and other pressures, are prioritizing self-care and mental wellness. In this context, Cannabidiol (CBD) has emerged as a beacon of hope. CBD, a non-psychoactive compound derived from cannabis, aligns perfectly with the rising focus on well-being. Consequently, the CBD market has experienced rapid growth, thanks to the proliferation of CBD products and its integration into various sectors, such as edibles, skincare, and online distribution channels.

Moreover, progressive policy reforms are playing a pivotal role in shaping the cannabis industry’s future. As governments recognize the economic and medical potential of cannabis, many are revising their regulations to accommodate its responsible use. These policy changes are removing barriers to entry for businesses, creating opportunities for innovation, and boosting market growth.

Regional Growth and Legalization

Regionally, the cannabis market is experiencing dynamic growth, with South America emerging as a notable hotspot. The legalization of medical cannabis in countries like Uruguay and Colombia served as a catalyst for the industry’s development, later followed by Argentina, Brazil, Chile, and other South American nations. While personal cultivation for recreational use is legal in several countries, commercial sales are restricted to Uruguay. Many South American countries have also decriminalized the possession of small amounts for personal use, contributing to the industry’s steady ascent. Additionally, South America’s cannabis market benefits from factors such as favorable climates, low-cost labor, and minimal construction expenses compared to North America.

Make an Inquiry: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=201768301

Conclusion

The global cannabis market’s phenomenal growth, driven by medical applications, changing consumer preferences, and supportive policy reforms, paints a promising picture for the industry’s future. With an estimated worth projected to reach USD 82.3 billion by 2027, the cannabis market is not only a lucrative venture for businesses but also a source of potential relief and wellness for millions of individuals worldwide. As the industry continues to mature, it is essential for companies to adapt to emerging trends and maintain their commitment to product quality and consumer satisfaction, ensuring their lasting success in this dynamic sector.

Market Leader – Cannabis Market

The global cannabis market size is projected to grow from USD 10.3 billion in 2018 to USD 39.4 billion by 2023, at a Compound Annual Growth Rate (CAGR) of 30.7% during the forecast period. The major driving factors in the cannabis market are growing medicinal application of cannabis and increasing legalization of cannabis.

The global market for cannabis is dominated by major players such as Canopy Growth Corporation (Canada), Aurora Cannabis Inc. (Canada), Tikun Olam (Israel), Cannabis Science Inc. (US), Aphria Inc. (Canada), Maricann Group Inc. (Canada), Tilray Inc. (Canada), VIVO Cannabis Inc. (Canada), Medical Marijuana, Inc. (US), STENOCARE (Denmark), Cronos Group Inc. (Canada), Terra Tech Corp. (US), and MedMen (US). These players have adopted various growth strategies such as agreements, collaborations, joint ventures & partnerships, new product launches, expansions & investments, and acquisitions to expand their presence in the global cannabis market. Agreements, collaborations, joint ventures & partnerships have been the most dominating strategies adopted by the major players from 2013 to 2018. These strategies have helped them to tap the lucrative growth opportunities in the market and strengthen their market positions. Additionally, they have also helped them to increase their distribution channels.

Download PDF brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=201768301

Canopy Growth Corporation has been focusing on mergers & acquisitions and various agreements to expand its reach across different provinces of Canada as well as other countries such as Australia, Chile, Denmark, Lesotho, and Spain. The company is also strategizing to focus on upcoming products in the cannabis industry. For instance, in October 2018, the company acquired Eddu (Colorado) for the manufacturing of innovative products, such as cannabis-infused beverages. Moreover, Constellation Brands (US) has invested USD 4 billion in Canopy Growth Corporation to the company to strengthen its position and establish widespread operations across 30 countries.

Aurora Cannabis Inc. acquired and partnered with many companies to build a strong presence in terms of geographic reach, technology, production, and product offering. It is the only company that has launched a mobile application for ordering medically prescribed cannabis that will help the patients to order in a more user-friendly way. Additionally, to target the emerging consumption of cannabis among adults, it has been associating with liquor manufacturers to resell their recreational cannabis product. In September 2018, Aurora Cannabis Inc. acquired Agropro UAB (Lithuania) and Borela UAB (Lithuania) to extract and produce CBD-based wellness products for the European market.